Categories
The German Congress of Orthopaedics and Trauma Surgery

Despite the very varied nature of the scientific programme for The German Congress of Orthopaedics and Trauma Surgery (Berlin, 24-27 October), Congress President Professor Joachim Read more …
Novartis launched once-a-year osteoporosis treatment
The Swiss company Novartis recently received the FDA approval for the U.S. market for their new osteoporosis drug “Reclast”, a therapy that is only given once a year via a Read more …
Exclusive dry long film for digital CR/DR

XL, an exclusive, dry, long film for use in the Horizon XL printer - currently the only digital long film imager on the market – promises to not only to reduce costs, save space, Read more …
Hip revision with bone grafting using inorganic bone mineral matrix
The new European Transplantation Regulation makes it very difficult, or even impossible, to run a bone bank from 2007 onwards.
Read more …
Fracture risk prediction osteoporosis patients
Simple clinical measurements raise hope of targeted treatments for those at highest risk. The future risk of osteoporotic fracture can be predicted with 75% accuracy using a new Read more …
Treatment of orthopaedic patients to accelerate

UK – Around 10 million people suffer from musculoskeletal ailments in England alone. Read more …


.jpg&contenttype=jpeg)



